H 
8.21
+2.11%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥22.90bn
FY2018FY2025
Net income
CN¥277.7m
FY2018FY2025
Free cash flow
CN¥327.2m
FY2018FY2025
Shareholders' equity
CN¥3.28bn
FY2018FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥22.90bn | CN¥15.75bn | CN¥12.39bn | CN¥10.27bn | CN¥8.17bn | CN¥4.84bn | CN¥2.11bn | CN¥993.3m |
| Gross profit | CN¥1.44bn | CN¥1.07bn | CN¥794.7m | CN¥413.4m | CN¥94.8m | −CN¥188.5m | −CN¥336.2m | −CN¥231.4m |
| Research and development | CN¥114.6m | CN¥108.1m | CN¥91.7m | CN¥96.6m | CN¥123.4m | CN¥69.4m | CN¥4.3m | — |
| Operating income | CN¥278.5m | CN¥117.3m | CN¥19.2m | −CN¥331.3m | −CN¥913.0m | −CN¥769.2m | −CN¥573.4m | −CN¥361.6m |
| Net income | CN¥277.7m | CN¥132.5m | CN¥50.6m | −CN¥286.9m | −CN¥898.9m | −CN¥757.7m | −CN¥469.8m | −CN¥328.4m |
| Diluted earnings per share | 0.30 | 0.14 | 0.05 | -0.31 | -0.98 | -0.83 | -0.51 | -0.36 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥5.47bn | CN¥4.67bn | CN¥4.20bn | CN¥4.10bn | CN¥4.21bn | CN¥1.41bn | CN¥938.9m | CN¥222.3m |
| Cash and short-term investments | CN¥2.65bn | CN¥2.49bn | CN¥2.42bn | CN¥2.06bn | CN¥2.87bn | CN¥263.5m | CN¥71.3m | — |
| Total liabilities | CN¥2.19bn | CN¥1.71bn | CN¥1.22bn | CN¥1.09bn | CN¥899.5m | CN¥1.05bn | CN¥1.06bn | CN¥754.3m |
| Debt | CN¥16.0m | CN¥9.1m | CN¥11.5m | CN¥17.3m | CN¥20.5m | CN¥392.8m | CN¥584.9m | — |
| Shareholders' equity | CN¥3.28bn | CN¥2.96bn | CN¥2.98bn | CN¥3.02bn | CN¥3.31bn | CN¥365.5m | −CN¥116.4m | −CN¥532.0m |
| Shares outstanding | 914m | 914m | 933m | 933m | 914m | 914m | 914m | 914m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥394.8m | CN¥271.9m | CN¥266.3m | −CN¥414.7m | −CN¥532.1m | −CN¥563.5m | −CN¥655.9m | −CN¥366.5m |
| Capital spending | −CN¥67.6m | −CN¥47.7m | −CN¥69.0m | −CN¥9.4m | −CN¥17.1m | −CN¥8.4m | −CN¥2.8m | −CN¥57.8m |
| Free cash flow | CN¥327.2m | CN¥224.2m | CN¥197.3m | −CN¥424.0m | −CN¥549.2m | −CN¥571.9m | −CN¥658.8m | −CN¥424.3m |
| Dividends paid | — | — | — | — | — | −CN¥75.0m | −CN¥75.0m | — |
Latest quarters
By quarter end
| Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Dec 2022 | Jun 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥12.66bn | CN¥10.24bn | CN¥8.87bn | CN¥6.88bn | CN¥6.64bn | CN¥5.75bn | CN¥5.78bn | CN¥4.46bn |
| Gross profit | CN¥763.7m | CN¥680.8m | CN¥598.2m | CN¥473.3m | CN¥411.3m | CN¥383.4m | CN¥233.2m | CN¥180.6m |
| Operating income | CN¥128.3m | CN¥150.1m | CN¥54.7m | CN¥62.6m | −CN¥9.4m | CN¥28.6m | −CN¥165.6m | −CN¥136.0m |
| Net income | CN¥140.7m | CN¥137.0m | CN¥70.3m | CN¥62.2m | CN¥20.3m | CN¥30.3m | −CN¥143.0m | −CN¥143.9m |
| Diluted earnings per share | 0.15 | 0.15 | 0.08 | 0.07 | 0.02 | 0.03 | -0.15 | -0.15 |
| Cash from operations | — | −CN¥62.0m | CN¥271.0m | CN¥99.0m | CN¥266.0m | CN¥17.0m | −CN¥81.0m | −CN¥251.0m |
| Capital spending | — | −CN¥40.0m | −CN¥47.0m | −CN¥28.0m | −CN¥68.0m | −CN¥1.0m | −CN¥1.0m | −CN¥57.0m |
| Free cash flow | — | −CN¥102.0m | CN¥224.0m | CN¥71.0m | CN¥198.0m | CN¥16.0m | −CN¥82.0m | −CN¥308.0m |
| Total assets | CN¥5.47bn | CN¥5.08bn | CN¥4.67bn | CN¥4.26bn | CN¥4.20bn | CN¥4.04bn | CN¥4.10bn | CN¥4.01bn |
| Cash and short-term investments | CN¥2.65bn | CN¥2.40bn | CN¥2.49bn | CN¥2.37bn | CN¥2.42bn | CN¥2.32bn | CN¥2.06bn | CN¥2.29bn |
| Debt | CN¥16.0m | CN¥6.4m | CN¥9.1m | CN¥7.4m | CN¥11.5m | CN¥11.1m | CN¥17.3m | CN¥16.3m |
| Shareholders' equity | CN¥3.28bn | CN¥3.11bn | CN¥2.96bn | CN¥2.91bn | CN¥2.98bn | CN¥3.05bn | CN¥3.02bn | CN¥3.17bn |
Financial ratios
Data as of 5 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 6.3% | 6.8% | 6.4% | 4.0% | 1.2% | -3.9% | — |
| Operating margin | 1.2% | 0.7% | 0.2% | -3.2% | -11.2% | -15.9% | — |
| Net margin | 1.2% | 0.8% | 0.4% | -2.8% | -11.0% | -15.6% | — |
| Return on equity | 8.5% | 4.5% | 1.7% | -9.5% | -27.2% | -207.3% | — |
| Return on assets | 5.1% | 2.8% | 1.2% | -7.0% | -21.4% | -53.6% | — |
| Free cash flow yield | 6.1% | 4.2% | 4.3% | -5.2% | — | — | — |
| Revenue growth | 45.4% | 27.1% | 20.7% | 25.6% | 68.8% | 129.9% | — |
| Earnings growth | 109.7% | 161.8% | -117.6% | -68.1% | 18.6% | 61.3% | — |
| Current ratio | 2.29x | 2.51x | 3.13x | 3.20x | 4.36x | 1.06x | — |
| Debt to equity | — | 0.00x | 0.00x | 0.00x | 0.00x | 1.00x | -4.87x |
| Equity ratio | 60.0% | 63.4% | 71.0% | 73.5% | 78.6% | 25.9% | — |
| Interest coverage | 378.85x | 5.81x | 1.21x | -17.35x | -73.12x | -271.78x | — |
| R&D as a share of sales | 0.5% | 0.7% | 0.7% | 0.9% | 1.5% | 1.4% | — |
| Buybacks as a share of market value | 0.0% | 2.1% | 0.0% | — | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 30.7% | 36.4% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 6.5% | 6.1% | 4.9% | — |
| Operating margin | 1.0% | 0.1% | -2.2% | — |
| Net margin | 1.1% | 0.3% | -2.0% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Price to earnings | 31.5 | 55.5 | 165.9 | -21.1 | -14.5 |
| Price to sales | 0.4 | 0.5 | 0.7 | 0.6 | 1.6 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.